So in May 2023 AZD0466 was still reported to perform very well:
Treatment with AZD0466 is well tolerated in pts with R/R acute leukemia, with AEs matching expected toxicity from preclinical data. Preclinical efficacy modelling and clinical PK data suggest further dose escalation is warranted to explore clinical activity.
Maybe since the last week we are listening to the prelude to taking over Starpharma.
- Forums
- ASX - By Stock
- SPL
- Ann: Trading Halt
Ann: Trading Halt, page-116
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.17M |
Open | High | Low | Value | Volume |
9.8¢ | 9.8¢ | 9.2¢ | $164.2K | 1.726M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 241449 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 74940 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 241449 | 0.095 |
1 | 50000 | 0.094 |
1 | 227075 | 0.093 |
1 | 43260 | 0.092 |
1 | 50050 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 74940 | 2 |
0.100 | 108705 | 3 |
0.105 | 106531 | 5 |
0.110 | 39609 | 6 |
0.115 | 138531 | 6 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online